Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Gains from Investment Securities (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Gains from Investment Securities data on record, last reported at $4.4 million in Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 3796.14% to $4.4 million in Q1 2026 year-over-year; TTM through Sep 2025 was $4.7 million, a 43.73% increase, with the full-year FY2025 number at $14.4 million, up 27.1% from a year prior.
  • Gains from Investment Securities reached $4.4 million in Q1 2026 per OLMA's latest filing, down from $4.7 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for OLMA hit a ceiling of $11.4 million in Q4 2024 and a floor of $106016.0 in Q1 2024.
  • A 5-year average of $5.5 million and a median of $4.6 million in 2025 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 9401.7% in 2022, then tumbled 98.92% in 2024.
  • Tracing OLMA's Gains from Investment Securities over 5 years: stood at $8.4 million in 2022, then rose by 3.41% to $8.7 million in 2023, then soared by 30.94% to $11.4 million in 2024, then tumbled by 58.25% to $4.7 million in 2025, then decreased by 7.01% to $4.4 million in 2026.
  • Business Quant data shows Gains from Investment Securities for OLMA at $4.4 million in Q1 2026, $4.7 million in Q3 2025, and $4.2 million in Q2 2025.